Some of those outbreaks which occurred before the days of polio vaccinations may have been similar enough to polio virus to lead to some level of immunity from polio in people affected. This may be of historical interest, but is irrelevant now since polio has been practically eliminated world wide through vaccination.
Yes, but I do think the outbreaks themselves are of interest as they are a unique opportunity to study the disease and have *very* high rates of long-term disability as compared to, say, the flu. It's possible that that strain(s) came and went and we just don't see enteroviral outbreaks like that anymore. Regardless of which infections cause them, we should be aware of and on the hunt for clusters (which do still happen). We may start to "see" clusters again as an organic outgrowth of greater medical education and scientific awareness of the condition.
Some of these outbreaks seem to have triggered enough cases to be noticeable of a long term disabling chronic illness which was probably what we now call ME, defined by PEM and muscle fatiguability among many other symptoms.
The epidemics were also noticeable in the acute stage. Many did not follow patients for more than a few months. Some did do longer-term follow-ups. Regardless, the condition was recognizable in its earliest stages due to the onset, symptoms, course, spread.
And it was definitely what we now call ME. Our definition/idea of ME
came from these epidemics.
Many people with ME can pin the start of their ME to an acute viral infection of many different types including mononucleosis, Coxsackie (an enterovirus), influenza, and other viral infections of unknown specific viral origin, the acute symptoms of which resolved quickly but chronic symptoms started immediately following the acute infection.
Right
The chronic symptoms of ME are usually different from the symptoms of the acute infection that triggered it. Viruses have not been found in blood of most ME sufferers. There is not sufficient evidence of sufficient quality or quantity to show whether any virus remains within some tissues of ME sufferers.
Again, in these outbreaks the "chronic" symptoms were observable very quickly. I think it was 4-7 days incubation, 1 week prodromal symptoms, and then as soon as 1-2 weeks after that, the CNS, ANS and muscle involvement. Some noted that second phase came later, but in many cases it was super quick.
Many ME sufferers are likely to have herpes virus in nerve cells because there is a high prevalence of herpes in the population, and once in the system, herpes is there for life, lurking in nerve cells. Antivirals can reduce the symptoms of a flare of herpes symptoms, but don't get rid of the herpes stored in the nerve cells. Most people with herpes don't have ME. There is no evidence that herpes has a higher prevalence in ME than in the rest of the population. (has this been investigated?)
I don't know if it has been. 99% of people with MS have EBV (v. maybe 85% of gen pop), so it's considered a necessary but not sufficient condition. We may come to find that herpesviruses are not the causes but rather the mediators/mechanisms of a wide range of diseases:
http://me-pedia.org/wiki/Epstein-Barr_virus#In_human_disease
Flares of herpes simplex are nothing like ME, so reactiviation of herpes virus is not ME. A flare up of varicella zoster (chickenpox) produces shingles - again nothing like ME. So it seems reactivation of these viruses does not lead to ME symptoms. If some other virus, such as an enterovirus, is lurking within cells of some ME sufferers, there is no logical reason to believe it will cause ME symptoms either - it might, but its presence within cells is not evidence that it is causing ME symptoms.
My ME symptoms used to flare *horribly* (go to the ER horrible) every time I had an HSV1 outbreak. Antivirals prevent this and have raised my baseline. Don't know why. Really lucky I don't need a clinical trial to have access to them.
Most people with ME didn't have an enterovirus as the trigger but had some other virus or a bacteria or something else as trigger. Is it plausible that the same symptom pattern resulting from all these different triggers, most of which are not still present in the cells, would result from lurking viruses in tissues in a subset of ME patients?
We have no idea what the trigger is for most people so we have no idea whether most people had an enterovirus or not. I imagine it's a significant subset, just like mono is a significant subset but giardia is probably less common. Some of this will have to do with how common the exposures/infections are. It will also related to which infectious agents can cause these changes (I imagine some will be more likely to than others).
Also, it may be that trigger relates to symptoms. For example, I know people with ME who have cognitive dysfunction and PEM but little or no muscle involvement. I have comparatively little cognitive dysfunction but major muscle PEM. If my trigger was Coxsackie B4, and Coxsackie has a tropism for muscle cells, maybe the trigger does relate to the symptom. It could also relate to site(s) of initial infection (even if no persistence), genetics, a host of other things. But an interesting question to ask. I would be surprised if the nature of the trigger matters nothing and we all arrive at some generic end state. It's a complex interaction of environment, host genes, infectious agent's genes.
Should there be better research to look for viruses in tissues? Is there any point?
Absolutely. See:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528287/ Understanding what viruses are doing on the epigenetic level is important.
Should there be large clinical trials of different antivirals and antiretrovirals for ME? As I understand it, there is no antiviral treatment that eliminates viruses for chronic viral infections like HIV and herpes. That would suggest that it is not possible, with current drugs, to eliminate enterovirus chronically lodged in tissues, so would not be a cure, but a long term treatment, with all the risks that carries.
I don't think this makes sense until we understand
why would we be using antivirals. I think there is a good chance we'd be applying treatments to a heterogenous population and getting murky or null results for interventions that might work for a more clearly-defined subset. For example, if we had a better way to measure a smoldering herpesvirus, we would do a trial of herpesvirus drugs *only* on those patients. I was having recurrent HSV1 outbreaks. I know people who get shingles monthly. Maybe that would be a good place to start. But we'd need to be clear on what subsets we are talking about.
Similarly, I think it would be worth trialling an antienteroviral if we had one, but only, say, on a population with high titers to Coxsackie and confirmed viral RNA via biopsy.
I think we can get specific then yes, absolutely we should trial these drugs.
I was just thinking that both sides have made good arguments but being convincing is not getting us anywhere. We do need to test all likely theories till we figure out the problem. That said we have very limited resources so we need to allocate very strategically but i really do think arguing back and forth won't get us the answer because the evidence is not giving us a clear direction.
I disagree re: limited resources. The world is vast and sits on a sea of trillions of dollars. It's always a mistake to think of what we have as a fixed pie. We can and will attract more interest. And certainly the NIH keeps asking for more applications. As for private donors, some give because they believe in a certain organization. Others because they
want to see a certain theory tested. Having more high-quality work being done in new areas will just increase the opportunities for new funders. Some donors are generalists and will support the whole field, but I know of people who could give but sit on the sidelines because they don't see the work that would motivate them to give.
Who knows? Maybe we can get Gates obsessed/intrigued by enteroviruses given his interest in polio.
I would not be so sure. Arguing back and forth was what got me to understanding enough about rheumatoid arthritis to develop an entirely novel treatment. We eventually realised all the evidence we needed was already available! I find arguing very helpful because at the end of it I tend to have a much clearer idea of the topic than when I started. And these illnesses are hugely complicated so getting ideas clear can make a big difference.
Absolutely! I've learned so much from this discussion, including the homework I still need to go do.